Qiu C, Feng D. Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis. World J Clin Cases 2023; 11(28): 6725-6732 [PMID: 37901022 DOI: 10.12998/wjcc.v11.i28.6725]
Corresponding Author of This Article
Chen Qiu, MD, Doctor, Department of Pharmacy, Hongshan District Health Service Center, No. 70 Nanhu Road, Hongshan District, Wuhan 430000, Hubei Province, China. qc07200@163.com
Research Domain of This Article
Otorhinolaryngology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 3 Comparison of serum inflammatory indexes between the two groups (mean ± SD)
Group
IL-6 (ng/L)
TNF-α (pg/L)
IL-10 (ng/L)
sICAM-1 (μg/L)
LTD4 (mg/kg)
Control group
Before therapy
11.78 ± 2.32
55.34 ± 7.40
26.51 ± 6.32
40.78 ± 7.32
517.94 ± 23.40
After treatment
6.62 ± 1.66
22.76 ± 6.64
16.55 ± 6.11
32.62 ± 5.66
206.96 ± 19.24
Observation group
Before therapy
11.78 ± 2.32
55.28 ± 7.80
26.81 ± 4.39
40.93 ± 7.27
517.75 ± 10.44
After treatment
4.62 ± 0.66
19.19 ± 4.74
13.41 ± 3.31
26.74 ± 3.23
158.37 ± 10.37
Table 4 Comparison of adverse reactions between the two groups of patients (mean ± SD)
Group
Dry nose
Dry throat discomfort
Bitter
Minor erosive osmosis of nasal mucosa
Adverse reaction rate
Control group (40)
1
3
4
3
11 (27.5)
Observation group (40)
0
2
1
0
3 (7.5)
t value
5.541
P value
0.019
Citation: Qiu C, Feng D. Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis. World J Clin Cases 2023; 11(28): 6725-6732